News
Norgine gets first EU approval for WHIM syndrome therapy
Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, Norgine's Xolremdi.
Market Access
Health, growth & renewal: ABPI 2026 looks to UK’s future
The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.
News
GSK eyes October FDA verdict on chronic hep B drug
GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a verdict by 26th October.
Market Access
The companies shaping the UK’s commercial landscape
Which companies are working with the government to implement the US-UK pharmaceutical trade agreement?
News
FDA grants three priority vouchers to psychedelics
The FDA dropped a surprise Friday announcement that three more National Priority Vouchers would be given to a trio of psychedelics companies.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
